Timothy M. Mayleben, Director at Loxo Oncology, Inc. (LOXO), sold 6,000 shares at $75.85 ($455K) on 2017-11-22, disclosed to the SEC on 2017-11-27.
Open-market sale of $455k LOXO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.85 | 3,000 | $228K | 50.0% |
| 2 | $75.85 | 3,000 | $228K | 50.0% |
| Total | $75.85 avg | 6,000 | $455K | 100% |
| Filing → |
| ESPR | BUY | 2019-11-08 | $370K | — | Filing → |
| ESPR | BUY | 2019-09-06 | $259K | — | Filing → |
| ESPR | BUY | 2019-08-02 | $198K | — | Filing → |